Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
HLF Stock Summary
In the News
Why Herbalife Stock Popped Today
Herbalife replaced its CFO and announced improved guidance for 2024 today. Management cited "more stability in the business" for the positive outlook adjustment.
Real World vs. Theoretical Investing: Part 2
Investing in the real-world and investing in theory are worlds apart. Stock Strategist Andrew Rocco provides the details you need to know to succeed and profit in the real-world.
Shorting: Is the Risk Worth the Reward? (Insights from Market Gurus & the Pitfalls you Need to Avoid)
On shorter time frames, markets fluctuate, and there is a time to be short. However, investors should focus on long opportunities more often than not as risks are much lower and the risk-to-reward is much more favorable, all else equal.
Kamala Harris disregarded staff recommendation to investigate Herbalife — while husband Doug Emhoff's firm repped the company
An internal memo shows Harris was urged to investigate Herbalife by her California AG staff while her husband worked for the law firm representing it.
Herbalife (HLF) stock: Technicals point to a 62% dive
Herbalife (NYSE: HLF) stock price has imploded in a strong vindication for Bill Ackman, the billionaire who lost a billion dollars shorting it a few years ago. The stock plunged by more than 31% on Thursday as Ackman celebrated the downfall.
Why Herbalife Stock Plummeted Today
Herbalife delivered far lower-than-expected earnings in the fourth quarter amid its ongoing "transformation program." The supplement company also told investors to expect flat revenue in the coming year.
Herbalife's stock plunges 30%, and Bill Ackman revives his ‘pyramid' scheme attack
Shares of Herbalife Ltd. fell more than 30% on Thursday, leading activist investor Bill Ackman to revive his feud with the nutritional-supplements company.
Herbalife Ltd. (HLF) Q4 2023 Earnings Call Transcript
Herbalife Ltd. (HLF) Q4 2023 Earnings Call Transcript
Bill Ackman's Pershing Square re-enters ranks of world's 20 top performing hedge funds
Bill Ackman's Pershing Square Capital Management has re-entered the ranks of the world's 20 best performing hedge funds following a bumper year for the New York money manager after it previously dropped off the list in 2015.
3 Stocks to Sell in January Before They Crash and Burn
U.S. equities are not off to a great start in 2024. The Nasdaq is down two-quarters of a percentage point, while the S&P 500 is largely flat.
HLF Financial details
HLF Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 35.5 | 42.14 | 54.8 | 52.84 | 51.14 | |
Net income per share | 2.26 | 2.83 | 4.22 | 3.26 | 1.44 | |
Operating cash flow per share | 3.33 | 4.78 | 4.35 | 3.58 | 3.61 | |
Free cash flow per share | 2.56 | 3.93 | 2.92 | 1.99 | 2.25 | |
Cash per share | 6.11 | 7.95 | 5.68 | 5.16 | 5.42 | |
Book value per share | -2.84 | -6.51 | -13.14 | -12.85 | -10.71 | |
Tangible book value per share | -5.76 | -9.66 | -17.04 | -17 | -14.85 | |
Share holders equity per share | -2.84 | -6.51 | -13.14 | -12.85 | -10.71 | |
Interest debt per share | 15.32 | 20.98 | 29.39 | 30.64 | 29.65 | |
Market cap | 6.55B | 6.32B | 4.33B | 1.47B | 1.51B | |
Enterprise value | 7.68B | 7.91B | 6.7B | 3.84B | 3.71B | |
P/E ratio | 21.06 | 16.96 | 9.69 | 4.56 | 10.62 | |
Price to sales ratio | 1.34 | 1.14 | 0.75 | 0.28 | 0.3 | |
POCF ratio | 14.32 | 10.05 | 9.42 | 4.16 | 4.23 | |
PFCF ratio | 18.64 | 12.23 | 14.03 | 7.47 | 6.79 | |
P/B Ratio | -16.79 | -7.38 | -3.11 | -1.16 | -1.42 | |
PTB ratio | -16.79 | -7.38 | -3.11 | -1.16 | -1.42 | |
EV to sales | 1.58 | 1.43 | 1.15 | 0.74 | 0.73 | |
Enterprise value over EBITDA | 11.27 | 10.67 | 8.2 | 5.71 | 7.68 | |
EV to operating cash flow | 16.79 | 12.58 | 14.55 | 10.9 | 10.36 | |
EV to free cash flow | 21.86 | 15.31 | 21.68 | 19.59 | 16.65 | |
Earnings yield | 0.05 | 0.06 | 0.1 | 0.22 | 0.09 | |
Free cash flow yield | 0.05 | 0.08 | 0.07 | 0.13 | 0.15 | |
Debt to equity | -5.06 | -3.08 | -2.13 | -2.28 | -2.61 | |
Debt to assets | 0.74 | 0.86 | 1.05 | 1.06 | 0.99 | |
Net debt to EBITDA | 1.66 | 2.15 | 2.89 | 3.53 | 4.55 | |
Current ratio | 1.54 | 1.58 | 1.33 | 1.39 | 1.1 | |
Interest coverage | 4.29 | 5.16 | 4.94 | 4.09 | 2.15 | |
Income quality | 1.47 | 1.69 | 1.03 | 1.1 | 2.51 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.39 | 0.37 | 0.34 | 0.34 | 0.36 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.15 | 0.13 | 0.15 | 0.15 | 0.15 | |
Capex to operating cash flow | -0.23 | -0.18 | -0.33 | -0.44 | -0.38 | |
Capex to revenue | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 | |
Capex to depreciation | -1.09 | -1.12 | -1.41 | -1.36 | -1.19 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 12.02 | 20.37 | 35.33 | 30.71 | 18.6 | |
ROIC | 0.22 | 0.23 | 0.33 | 0.23 | 0.13 | |
Return on tangible assets | 0.14 | 0.14 | 0.19 | 0.14 | 0.06 | |
Graham Net | -14.2 | -19.57 | -30.89 | -31.94 | -30.5 | |
Working capital | 523.8M | 648.5M | 351.4M | 379.5M | 121.7M | |
Tangible asset value | -791.6M | -1.27B | -1.8B | -1.67B | -1.47B | |
Net current asset value | -1.58B | -2.16B | -2.78B | -2.64B | -2.47B | |
Invested capital | -5.06 | -3.08 | -2.13 | -2.28 | -2.61 | |
Average receivables | 75.1M | 81.5M | 75.1M | 68.75M | 75.9M | |
Average payables | 81.35M | 85.15M | 90.35M | 90.9M | 86.9M | |
Average inventory | 409M | 468.8M | 538.55M | 578.2M | 542.95M | |
Days sales outstanding | 5.96 | 5.49 | 4.21 | 4.95 | 5.85 | |
Days payables outstanding | 31.09 | 28.14 | 27.1 | 27.93 | 25.74 | |
Days of inventory on hand | 166.19 | 159.06 | 169.56 | 180.6 | 154.83 | |
Receivables turnover | 61.19 | 66.53 | 86.74 | 73.72 | 62.34 | |
Payables turnover | 11.74 | 12.97 | 13.47 | 13.07 | 14.18 | |
Inventory turnover | 2.2 | 2.29 | 2.15 | 2.02 | 2.36 | |
ROE | -0.8 | -0.44 | -0.32 | -0.25 | -0.13 | |
Capex per share | -0.77 | -0.85 | -1.43 | -1.59 | -1.36 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 12.04 | 12.71 | 13.26 | 12.92 | 12.24 | |
Net income per share | 0.55 | 0.3 | 0.6 | 0.43 | 0.1 | |
Operating cash flow per share | 0.55 | 0.47 | 1.37 | 0.8 | 0.97 | |
Free cash flow per share | 0.11 | 0.16 | 0.98 | 0.49 | 0.61 | |
Cash per share | 5.18 | 4.61 | 5.31 | 5 | 5.4 | |
Book value per share | -12.9 | -12.41 | -11.61 | -11.12 | -10.68 | |
Tangible book value per share | -17.07 | -16.57 | -15.74 | -15.23 | -14.8 | |
Share holders equity per share | -12.9 | -12.41 | -11.61 | -11.12 | -10.68 | |
Interest debt per share | 29.78 | 28.98 | 29.11 | 28.25 | 28.31 | |
Market cap | 1.46B | 1.59B | 1.31B | 1.39B | 1.52B | |
Enterprise value | 3.84B | 3.95B | 3.63B | 3.66B | 3.71B | |
P/E ratio | 6.71 | 13.53 | 5.48 | 8.11 | 37.14 | |
Price to sales ratio | 1.24 | 1.27 | 1 | 1.08 | 1.25 | |
POCF ratio | 27.23 | 34.33 | 9.68 | 17.43 | 15.77 | |
PFCF ratio | 135.16 | 99.74 | 13.48 | 28.61 | 24.92 | |
P/B Ratio | -1.15 | -1.3 | -1.14 | -1.26 | -1.43 | |
PTB ratio | -1.15 | -1.3 | -1.14 | -1.26 | -1.43 | |
EV to sales | 3.25 | 3.15 | 2.76 | 2.85 | 3.05 | |
Enterprise value over EBITDA | 37.72 | 40.24 | 23.38 | 34.27 | 42.54 | |
EV to operating cash flow | 71.57 | 85.44 | 26.76 | 45.93 | 38.6 | |
EV to free cash flow | 355.2 | 248.25 | 37.3 | 75.39 | 61.01 | |
Earnings yield | 0.04 | 0.02 | 0.05 | 0.03 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.07 | 0.03 | 0.04 | |
Debt to equity | -2.28 | -2.3 | -2.47 | -2.51 | -2.61 | |
Debt to assets | 1.06 | 1.05 | 1.03 | 1.01 | 0.99 | |
Net debt to EBITDA | 23.37 | 24.07 | 14.93 | 21.26 | 25.16 | |
Current ratio | 1.39 | 1.08 | 1.11 | 1.16 | 1.1 | |
Interest coverage | 2.38 | 1.79 | 3 | 2.77 | 1.35 | |
Income quality | 0.99 | 1.58 | 2.26 | 1.86 | 9.42 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.33 | 0 | 0 | 0 | 0.35 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | |
Capex to operating cash flow | -0.8 | -0.66 | -0.28 | -0.39 | -0.37 | |
Capex to revenue | -0.04 | -0.02 | -0.03 | -0.02 | -0.03 | |
Capex to depreciation | -1.52 | -1.1 | -1.32 | -1.1 | -1.25 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 12.69 | 9.12 | 12.56 | 10.39 | 4.97 | |
ROIC | 0.04 | 0.04 | 0.05 | 0.04 | 0.02 | |
Return on tangible assets | 0.02 | 0.01 | 0.03 | 0.02 | 0 | |
Graham Net | -32.07 | -31.67 | -30.95 | -30.49 | -30.41 | |
Working capital | 379.5M | 95M | 130.6M | 180.7M | 121.7M | |
Tangible asset value | -1.67B | -1.63B | -1.56B | -1.51B | -1.47B | |
Net current asset value | -2.64B | -2.59B | -2.55B | -2.48B | -2.47B | |
Invested capital | -2.28 | -2.3 | -2.47 | -2.51 | -2.61 | |
Average receivables | 77.8M | 77.85M | 85.7M | 82.9M | 80.35M | |
Average payables | 87.15M | 78.85M | 78.25M | 83.25M | 80.95M | |
Average inventory | 558.85M | 562.9M | 535.1M | 510.95M | 501M | |
Days sales outstanding | 5.38 | 6.12 | 5.91 | 5.58 | 6.01 | |
Days payables outstanding | 30.43 | 20.47 | 26.44 | 23.12 | 26.29 | |
Days of inventory on hand | 196.77 | 164.3 | 156.69 | 147.47 | 158.09 | |
Receivables turnover | 16.73 | 14.71 | 15.23 | 16.12 | 14.96 | |
Payables turnover | 2.96 | 4.4 | 3.4 | 3.89 | 3.42 | |
Inventory turnover | 0.46 | 0.55 | 0.57 | 0.61 | 0.57 | |
ROE | -0.04 | -0.02 | -0.05 | -0.04 | -0.01 | |
Capex per share | -0.44 | -0.31 | -0.39 | -0.31 | -0.36 |
HLF Frequently Asked Questions
What is Herbalife Nutrition Ltd. stock symbol ?
Herbalife Nutrition Ltd. is a US stock , located in Los angeles of Ca and trading under the symbol HLF
Is Herbalife Nutrition Ltd. buy or a sell ?
3 stock analysts have 3 predictions with a medium analyst target price of $18.5. The lowest prediction is $9.5 and the highest is $36
What is HLF stock prediction ?
With a median analyst target price of $9.75, 2 stock analysts have made 2 forecasts in last 90 days. $9.5 is the lowest and $10 is the greatest projection.
What is Herbalife Nutrition Ltd. stock quote today ?
Herbalife Nutrition Ltd. stock price is $10.065 today.
Is Herbalife Nutrition Ltd. stock public?
Yes, Herbalife Nutrition Ltd. is a publicly traded company.